STTK
Shattuck Labs Inc
NASDAQ: STTK · HEALTHCARE · BIOTECHNOLOGY
$7.15
+0.85% today
Updated 2026-04-30
Market cap
$583.49M
P/E ratio
—
P/S ratio
583.49x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $8
Volume
0.6M
Shattuck Labs Inc (STTK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-5,143.00%
ROE
-60.30%
ROA
-35.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $22.44M | $-7.39M | -10.54% | -27.40% | -32.92% |
| 2019 | $9.89M | $-23.98M | -195.52% | -253.53% | -242.56% |
| 2020 | $9.93M | $-35.44M | 100.00% | -371.76% | -356.71% |
| 2021 | $30.02M | $-44.97M | 95.40% | -150.81% | -149.83% |
| 2022 | $652000.00 | $-100.56M | 100.00% | -15,848.01% | -15,423.47% |
| 2023 | $1.66M | $-87.30M | -143.93% | -5,549.61% | -5,268.44% |
| 2024 | $5.72M | $-75.41M | 100.00% | -1,408.27% | -1,318.13% |
| 2025 | $1.00M | $-48.81M | -268.80% | -5,150.80% | -4,880.90% |